Skip to content

Wald Outreach for Wellness: Blood Pressure Outreach

Wald Outreach for Wellness

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04286568
Acronym
WOW
Enrollment
0
Registered
2020-02-27
Start date
2023-02-28
Completion date
2024-02-29
Last updated
2023-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension, Pre-hypertension

Keywords

Health Disparities, Outreach, Health Behavior, Under-served communities

Brief summary

The Wald Outreach Center will partner with Medicine for the Greater Good (MGG) to implement this pilot project called Wald Outreach for Wellness (WOW), a blood pressure outreach wellness intervention in a retail setting.

Detailed description

WOW aims to provide community members with a digital blood pressure monitor, health education, and health care navigation as practical strategies to improve community members' management of pre-hypertension, and to reduce associated burdens and risks related to hypertension health disparities. This approach to reaching populations who use retail settings has the potential to implement a health promotion and wellness strategy aimed at populations with increased risk for hypertension related health disparities. The outreach strategy is aimed at reaching community members where community members gather for health care, provide the community members with practical, low-cost strategies for promoting health and wellness, increase community members' knowledge in hypertension management, help the community members navigate health care options and get the community members engaged in a medical home thereby reducing the burdens of hypertension health disparities. This research is important to continue to assess the best ways to reach and reduce hypertension health disparities in underserved communities with limited access to health care.

Interventions

BEHAVIORALWOW Intervention

Health education and coaching, health care navigation,

Sponsors

Johns Hopkins University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

quasi-experimental non-randomized

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Community residents who participate in Day at the Market * Adult individuals 18 years and older whose recorded BP reading is within the pre-hypertensive range 120-139 systolic; 80-89 diastolic * Able to read and understand English

Exclusion criteria

* 17 years or younger * BP reading above pre-hypertensive range * Unable to read and understand English

Design outcomes

Primary

MeasureTime frameDescription
Change in actions to control hypertension as assessed by the Behavioral Risk Factor Surveillance System Module 7Assessed at baseline, 6 weeks and 12 weeksChange in yes/no answers assessed by Behavioral Risk Factor Surveillance System (BRFSS) Module 7. 10 questions graded by yes/no response.
Change in blood pressureAssessed at baseline and every 2 weeks, up to 3 monthsChange in blood pressure (BP) measured in mmHg.

Secondary

MeasureTime frameDescription
Change in usage of BP monitorAssessed at baseline and every 2 weeks, up to 3 monthsChange in usage of blood pressure monitor assessed by number of BP readings done by participants.
Change in knowledge of the signs and symptoms of a heart attack and stroke as assessed by BRFSS Module 8Assessed at baseline, 6 weeks and 12 weeksChange in knowledge (yes/no responses) of signs and symptoms of stroke/heart attack as assessed by BRFSS Module 8. 13 Questions graded by yes/no.
Change in engagement with healthcare provider as assessed by BRFSS Section 3Assessed at baseline, 6 weeks and 12 weeksChange in engagement with healthcare provider/medical home as assessed by BRFSS Section 3. 3 questions graded by yes/no.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026